Sales/Maturities of Investments

$10.68B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$10.68Bperiod endingJun 30, 2026

REGN TTM Sales/Maturities of Investments ($82.80M → $10.68B)

TTM Sales/Maturities of Investments

High-resolution chart · PNG

REGN sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2001	70,776,000
Mar 31, 2001	67,361,000
Dec 31, 2000	53,717,000
Sep 30, 2000	46,704,000
Jun 30, 2000	58,806,000
Mar 31, 2000	59,764,000
Dec 31, 1999	83,200,000
Sep 30, 1999	92,100,000
Jun 30, 1999	104,900,000
Mar 31, 1999	104,900,000
Dec 31, 1998	93,500,000
Sep 30, 1998	102,800,000
Jun 30, 1998	93,600,000
Mar 31, 1998	78,600,000
Dec 31, 1997	75,900,000
Sep 30, 1997	57,100,000
Jun 30, 1997	49,100,000
Mar 31, 1997	49,000,000
Dec 31, 1996	38,900,000
Sep 30, 1996	42,900,000
Jun 30, 1996	33,800,000
Mar 31, 1996	34,300,000
Dec 31, 1995	38,800,000
Sep 30, 1995	36,100,000
Jun 30, 1995	44,100,000
Mar 31, 1995	52,500,000
Dec 31, 1994	61,300,000
Sep 30, 1994	70,700,000
Jun 30, 1994	77,400,000
Mar 31, 1994	76,200,000
Dec 31, 1993	68,500,000
Sep 30, 1993	73,200,000
Jun 30, 1993	91,000,000
Mar 31, 1993	86,000,000
Dec 31, 1992	82,800,000
Sep 30, 1992	86,600,000
Jun 30, 1992	85,000,000